Ligand Pharmaceuticals Incorporated
LGND · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $72,307 | $22,954 | $45,006 | $19,522 |
| Short-Term Investments | $183,858 | $147,355 | $166,864 | $321,586 |
| Receivables | $42,449 | $39,312 | $35,038 | $91,646 |
| Inventory | $14,114 | $23,969 | $13,294 | $27,326 |
| Other Curr. Assets | $18,831 | $3,839 | $3,399 | $4,671 |
| Total Curr. Assets | $331,559 | $237,429 | $263,601 | $464,751 |
| Property Plant & Equip (Net) | $24,806 | $25,062 | $27,491 | $32,602 |
| Goodwill | $105,250 | $103,370 | $105,673 | $105,673 |
| Intangibles | $266,648 | $299,606 | $352,637 | $386,801 |
| Long-Term Investments | $10,908 | $111,612 | $3,000 | $0 |
| Tax Assets | $72 | $214 | $8,530 | $35,729 |
| Other NC Assets | $202,531 | $9,923 | $1,736 | $272,034 |
| Total NC Assets | $610,215 | $549,787 | $499,067 | $832,839 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $941,774 | $787,216 | $762,668 | $1,297,590 |
| Liabilities | – | – | – | – |
| Payables | $5,233 | $2,427 | $5,307 | $8,403 |
| Short-Term Debt | $1,290 | $410 | $77,410 | $1,413 |
| Tax Payable | $1,199 | $0 | $0 | $0 |
| Deferred Revenue | $1,899 | $1,843 | $976 | $654 |
| Other Curr. Liab. | $27,491 | $12,102 | $15,117 | $31,195 |
| Total Curr. Liab. | $37,112 | $16,782 | $98,810 | $41,665 |
| LT Debt | $5,815 | $5,755 | $10,336 | $322,973 |
| Deferred Rev, NC | $0 | $15,144 | $44 | $0 |
| Deferred Tax Liab, NC | $32,524 | $31,622 | $30,615 | $30,856 |
| Other NC Liab. | $35,884 | $17,000 | $25,378 | $80,937 |
| Total NC Liab. | $74,223 | $69,521 | $66,373 | $434,766 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $7,105 | $6,165 | $11,051 | $3,669 |
| Total Liabilities | $111,335 | $86,303 | $165,183 | $476,431 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $20 | $18 | $17 | $17 |
| Retained Earnings | $498,984 | $503,016 | $450,862 | $449,090 |
| AOCI | -$5,942 | -$817 | -$984 | -$917 |
| Other Equity | $337,377 | $198,696 | $147,590 | $372,969 |
| Total Equity | $830,439 | $700,913 | $597,485 | $821,159 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $941,774 | $787,216 | $762,668 | $1,297,590 |
| Net Debt | -$65,202 | -$16,789 | $42,740 | $304,864 |